(Q41081555)

26 September 2017

1 reference

title

Somatostatin analogs in ectopic corticotropin production (English)

1 reference

26 September 2017

von Werder K

1

1 reference

26 September 2017

Muller OA

series ordinal

2

1 reference

26 September 2017

Stalla GK

series ordinal

3

1 reference

26 September 2017

publication date

1 August 1996

1 reference

26 September 2017

1 reference

26 September 2017

volume

45

1 reference

26 September 2017

issue

8 Suppl 1

1 reference

26 September 2017

page(s)

129-131

1 reference

Octreotide exerts different effects in vivo and in vitro in Cushing's disease

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Somatostatin: A potent inhibitor of ACTH-Hypersecretion in adrenal insufficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin-secreting pancreatic islet cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Ectopic production of ACTH and corticotropin-releasing hormone (CRH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Long acting somatostatin treatment of paraneoplastic Cushing's syndrome in a case of Zollinger-Ellison syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Failure of somatostatin analogue SMS 201-995 to control Cushing's syndrome due to ectopic release of ACTH from a bronchial carcinoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990107-9

10.1016/S0026-0495(96)90107-9

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference